Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biological Drug CDMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Innovative Drug
1.2.3 Listed Patent Drugs
1.2.4 Biosimilar
1.3 Market by Application
1.3.1 Global Biological Drug CDMO Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biological Drug CDMO Market Perspective (2018-2033)
2.2 Biological Drug CDMO Growth Trends by Region
2.2.1 Global Biological Drug CDMO Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Biological Drug CDMO Historic Market Size by Region (2018-2023)
2.2.3 Biological Drug CDMO Forecasted Market Size by Region (2024-2033)
2.3 Biological Drug CDMO Market Dynamics
2.3.1 Biological Drug CDMO Industry Trends
2.3.2 Biological Drug CDMO Market Drivers
2.3.3 Biological Drug CDMO Market Challenges
2.3.4 Biological Drug CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biological Drug CDMO Players by Revenue
3.1.1 Global Top Biological Drug CDMO Players by Revenue (2018-2023)
3.1.2 Global Biological Drug CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Biological Drug CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biological Drug CDMO Revenue
3.4 Global Biological Drug CDMO Market Concentration Ratio
3.4.1 Global Biological Drug CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biological Drug CDMO Revenue in 2022
3.5 Biological Drug CDMO Key Players Head office and Area Served
3.6 Key Players Biological Drug CDMO Product Solution and Service
3.7 Date of Enter into Biological Drug CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biological Drug CDMO Breakdown Data by Type
4.1 Global Biological Drug CDMO Historic Market Size by Type (2018-2023)
4.2 Global Biological Drug CDMO Forecasted Market Size by Type (2024-2033)
5 Biological Drug CDMO Breakdown Data by Application
5.1 Global Biological Drug CDMO Historic Market Size by Application (2018-2023)
5.2 Global Biological Drug CDMO Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Biological Drug CDMO Market Size (2018-2033)
6.2 North America Biological Drug CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Biological Drug CDMO Market Size by Country (2018-2023)
6.4 North America Biological Drug CDMO Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biological Drug CDMO Market Size (2018-2033)
7.2 Europe Biological Drug CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Biological Drug CDMO Market Size by Country (2018-2023)
7.4 Europe Biological Drug CDMO Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biological Drug CDMO Market Size (2018-2033)
8.2 Asia-Pacific Biological Drug CDMO Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Biological Drug CDMO Market Size by Region (2018-2023)
8.4 Asia-Pacific Biological Drug CDMO Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biological Drug CDMO Market Size (2018-2033)
9.2 Latin America Biological Drug CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Biological Drug CDMO Market Size by Country (2018-2023)
9.4 Latin America Biological Drug CDMO Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biological Drug CDMO Market Size (2018-2033)
10.2 Middle East & Africa Biological Drug CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Biological Drug CDMO Market Size by Country (2018-2023)
10.4 Middle East & Africa Biological Drug CDMO Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Samsung Biologics
11.1.1 Samsung Biologics Company Detail
11.1.2 Samsung Biologics Business Overview
11.1.3 Samsung Biologics Biological Drug CDMO Introduction
11.1.4 Samsung Biologics Revenue in Biological Drug CDMO Business (2018-2023)
11.1.5 Samsung Biologics Recent Development
11.2 Lonza
11.2.1 Lonza Company Detail
11.2.2 Lonza Business Overview
11.2.3 Lonza Biological Drug CDMO Introduction
11.2.4 Lonza Revenue in Biological Drug CDMO Business (2018-2023)
11.2.5 Lonza Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Biological Drug CDMO Introduction
11.3.4 Boehringer Ingelheim Revenue in Biological Drug CDMO Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Catalent
11.4.1 Catalent Company Detail
11.4.2 Catalent Business Overview
11.4.3 Catalent Biological Drug CDMO Introduction
11.4.4 Catalent Revenue in Biological Drug CDMO Business (2018-2023)
11.4.5 Catalent Recent Development
11.5 BioCentriq
11.5.1 BioCentriq Company Detail
11.5.2 BioCentriq Business Overview
11.5.3 BioCentriq Biological Drug CDMO Introduction
11.5.4 BioCentriq Revenue in Biological Drug CDMO Business (2018-2023)
11.5.5 BioCentriq Recent Development
11.6 FUJIFILM Diosynth Biotechnologies
11.6.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.6.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.6.3 FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Introduction
11.6.4 FUJIFILM Diosynth Biotechnologies Revenue in Biological Drug CDMO Business (2018-2023)
11.6.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Detail
11.7.2 Thermo Fisher Scientific Business Overview
11.7.3 Thermo Fisher Scientific Biological Drug CDMO Introduction
11.7.4 Thermo Fisher Scientific Revenue in Biological Drug CDMO Business (2018-2023)
11.7.5 Thermo Fisher Scientific Recent Development
11.8 Recipharm
11.8.1 Recipharm Company Detail
11.8.2 Recipharm Business Overview
11.8.3 Recipharm Biological Drug CDMO Introduction
11.8.4 Recipharm Revenue in Biological Drug CDMO Business (2018-2023)
11.8.5 Recipharm Recent Development
11.9 Delpharm
11.9.1 Delpharm Company Detail
11.9.2 Delpharm Business Overview
11.9.3 Delpharm Biological Drug CDMO Introduction
11.9.4 Delpharm Revenue in Biological Drug CDMO Business (2018-2023)
11.9.5 Delpharm Recent Development
11.10 Aenova
11.10.1 Aenova Company Detail
11.10.2 Aenova Business Overview
11.10.3 Aenova Biological Drug CDMO Introduction
11.10.4 Aenova Revenue in Biological Drug CDMO Business (2018-2023)
11.10.5 Aenova Recent Development
11.11 Siegfried
11.11.1 Siegfried Company Detail
11.11.2 Siegfried Business Overview
11.11.3 Siegfried Biological Drug CDMO Introduction
11.11.4 Siegfried Revenue in Biological Drug CDMO Business (2018-2023)
11.11.5 Siegfried Recent Development
11.12 WuXi Biologics
11.12.1 WuXi Biologics Company Detail
11.12.2 WuXi Biologics Business Overview
11.12.3 WuXi Biologics Biological Drug CDMO Introduction
11.12.4 WuXi Biologics Revenue in Biological Drug CDMO Business (2018-2023)
11.12.5 WuXi Biologics Recent Development
11.13 Obio Technology
11.13.1 Obio Technology Company Detail
11.13.2 Obio Technology Business Overview
11.13.3 Obio Technology Biological Drug CDMO Introduction
11.13.4 Obio Technology Revenue in Biological Drug CDMO Business (2018-2023)
11.13.5 Obio Technology Recent Development
11.14 Hepalink
11.14.1 Hepalink Company Detail
11.14.2 Hepalink Business Overview
11.14.3 Hepalink Biological Drug CDMO Introduction
11.14.4 Hepalink Revenue in Biological Drug CDMO Business (2018-2023)
11.14.5 Hepalink Recent Development
11.15 Pharmaron
11.15.1 Pharmaron Company Detail
11.15.2 Pharmaron Business Overview
11.15.3 Pharmaron Biological Drug CDMO Introduction
11.15.4 Pharmaron Revenue in Biological Drug CDMO Business (2018-2023)
11.15.5 Pharmaron Recent Development
11.16 ChemPartner
11.16.1 ChemPartner Company Detail
11.16.2 ChemPartner Business Overview
11.16.3 ChemPartner Biological Drug CDMO Introduction
11.16.4 ChemPartner Revenue in Biological Drug CDMO Business (2018-2023)
11.16.5 ChemPartner Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biological Drug CDMO Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Innovative Drug
Table 3. Key Players of Listed Patent Drugs
Table 4. Key Players of Biosimilar
Table 5. Global Biological Drug CDMO Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Biological Drug CDMO Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Biological Drug CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Biological Drug CDMO Market Share by Region (2018-2023)
Table 9. Global Biological Drug CDMO Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Biological Drug CDMO Market Share by Region (2024-2033)
Table 11. Biological Drug CDMO Market Trends
Table 12. Biological Drug CDMO Market Drivers
Table 13. Biological Drug CDMO Market Challenges
Table 14. Biological Drug CDMO Market Restraints
Table 15. Global Biological Drug CDMO Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Biological Drug CDMO Market Share by Players (2018-2023)
Table 17. Global Top Biological Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Drug CDMO as of 2022)
Table 18. Ranking of Global Top Biological Drug CDMO Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Biological Drug CDMO Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Biological Drug CDMO Product Solution and Service
Table 22. Date of Enter into Biological Drug CDMO Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Biological Drug CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Biological Drug CDMO Revenue Market Share by Type (2018-2023)
Table 26. Global Biological Drug CDMO Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Biological Drug CDMO Revenue Market Share by Type (2024-2033)
Table 28. Global Biological Drug CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Biological Drug CDMO Revenue Market Share by Application (2018-2023)
Table 30. Global Biological Drug CDMO Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Biological Drug CDMO Revenue Market Share by Application (2024-2033)
Table 32. North America Biological Drug CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Biological Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Biological Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Biological Drug CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Biological Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Biological Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Biological Drug CDMO Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Biological Drug CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Biological Drug CDMO Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Biological Drug CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Biological Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Biological Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Biological Drug CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Biological Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Biological Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 47. Samsung Biologics Company Detail
Table 48. Samsung Biologics Business Overview
Table 49. Samsung Biologics Biological Drug CDMO Product
Table 50. Samsung Biologics Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 51. Samsung Biologics Recent Development
Table 52. Lonza Company Detail
Table 53. Lonza Business Overview
Table 54. Lonza Biological Drug CDMO Product
Table 55. Lonza Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 56. Lonza Recent Development
Table 57. Boehringer Ingelheim Company Detail
Table 58. Boehringer Ingelheim Business Overview
Table 59. Boehringer Ingelheim Biological Drug CDMO Product
Table 60. Boehringer Ingelheim Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 61. Boehringer Ingelheim Recent Development
Table 62. Catalent Company Detail
Table 63. Catalent Business Overview
Table 64. Catalent Biological Drug CDMO Product
Table 65. Catalent Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 66. Catalent Recent Development
Table 67. BioCentriq Company Detail
Table 68. BioCentriq Business Overview
Table 69. BioCentriq Biological Drug CDMO Product
Table 70. BioCentriq Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 71. BioCentriq Recent Development
Table 72. FUJIFILM Diosynth Biotechnologies Company Detail
Table 73. FUJIFILM Diosynth Biotechnologies Business Overview
Table 74. FUJIFILM Diosynth Biotechnologies Biological Drug CDMO Product
Table 75. FUJIFILM Diosynth Biotechnologies Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 76. FUJIFILM Diosynth Biotechnologies Recent Development
Table 77. Thermo Fisher Scientific Company Detail
Table 78. Thermo Fisher Scientific Business Overview
Table 79. Thermo Fisher Scientific Biological Drug CDMO Product
Table 80. Thermo Fisher Scientific Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 81. Thermo Fisher Scientific Recent Development
Table 82. Recipharm Company Detail
Table 83. Recipharm Business Overview
Table 84. Recipharm Biological Drug CDMO Product
Table 85. Recipharm Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 86. Recipharm Recent Development
Table 87. Delpharm Company Detail
Table 88. Delpharm Business Overview
Table 89. Delpharm Biological Drug CDMO Product
Table 90. Delpharm Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 91. Delpharm Recent Development
Table 92. Aenova Company Detail
Table 93. Aenova Business Overview
Table 94. Aenova Biological Drug CDMO Product
Table 95. Aenova Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 96. Aenova Recent Development
Table 97. Siegfried Company Detail
Table 98. Siegfried Business Overview
Table 99. Siegfried Biological Drug CDMO Product
Table 100. Siegfried Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 101. Siegfried Recent Development
Table 102. WuXi Biologics Company Detail
Table 103. WuXi Biologics Business Overview
Table 104. WuXi Biologics Biological Drug CDMO Product
Table 105. WuXi Biologics Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 106. WuXi Biologics Recent Development
Table 107. Obio Technology Company Detail
Table 108. Obio Technology Business Overview
Table 109. Obio Technology Biological Drug CDMO Product
Table 110. Obio Technology Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 111. Obio Technology Recent Development
Table 112. Hepalink Company Detail
Table 113. Hepalink Business Overview
Table 114. Hepalink Biological Drug CDMO Product
Table 115. Hepalink Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 116. Hepalink Recent Development
Table 117. Pharmaron Company Detail
Table 118. Pharmaron Business Overview
Table 119. Pharmaron Biological Drug CDMO Product
Table 120. Pharmaron Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 121. Pharmaron Recent Development
Table 122. ChemPartner Company Detail
Table 123. ChemPartner Business Overview
Table 124. ChemPartner Biological Drug CDMO Product
Table 125. ChemPartner Revenue in Biological Drug CDMO Business (2018-2023) & (US$ Million)
Table 126. ChemPartner Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biological Drug CDMO Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Biological Drug CDMO Market Share by Type: 2022 VS 2033
Figure 3. Innovative Drug Features
Figure 4. Listed Patent Drugs Features
Figure 5. Biosimilar Features
Figure 6. Global Biological Drug CDMO Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Biological Drug CDMO Market Share by Application: 2022 VS 2033
Figure 8. Pharmaceutical Company Case Studies
Figure 9. Biotechnology Company Case Studies
Figure 10. Biological Drug CDMO Report Years Considered
Figure 11. Global Biological Drug CDMO Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Biological Drug CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Biological Drug CDMO Market Share by Region: 2022 VS 2033
Figure 14. Global Biological Drug CDMO Market Share by Players in 2022
Figure 15. Global Top Biological Drug CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological Drug CDMO as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Biological Drug CDMO Revenue in 2022
Figure 17. North America Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Biological Drug CDMO Market Share by Country (2018-2033)
Figure 19. United States Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Biological Drug CDMO Market Share by Country (2018-2033)
Figure 23. Germany Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Biological Drug CDMO Market Share by Region (2018-2033)
Figure 31. China Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Biological Drug CDMO Market Share by Country (2018-2033)
Figure 39. Mexico Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Biological Drug CDMO Market Share by Country (2018-2033)
Figure 43. Turkey Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Biological Drug CDMO Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Samsung Biologics Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 46. Lonza Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 48. Catalent Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 49. BioCentriq Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 50. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 52. Recipharm Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 53. Delpharm Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 54. Aenova Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 55. Siegfried Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 56. WuXi Biologics Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 57. Obio Technology Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 58. Hepalink Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 59. Pharmaron Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 60. ChemPartner Revenue Growth Rate in Biological Drug CDMO Business (2018-2023)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed